Patient Guide: A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 48 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04489771
Status: ACTIVE_NOT_RECRUITING
Condition: Carcinoma, Renal Cell
Phase: PHASE2

Where You Can Participate

This study is available at 48 locations across the country.

Top locations include:
  • • Washington, District of Columbia
  • • Miami, Florida
  • • Louisville, Kentucky
  • • And 45 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013) - Join Clinical Trial NCTNCT04489771

How to Join This Clinical Trial - NCTNCT04489771

Learn how to participate in this PHASE2 trial studying an investigational therapy for Carcinoma, Renal Cell. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Carcinoma, Renal Cell. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Carcinoma, Renal Cell
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04489771 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 48 locations. Find a study site near you:

Clinical Research Site

Washington, District of Columbia 20007 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33136 - United States

Status: Contact for availability

Clinical Research Site

Louisville, Kentucky 40207 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21237 - United States

Status: Contact for availability

Clinical Research Site

Lincoln, Nebraska 68510 - United States

Status: Contact for availability

Clinical Research Site

Omaha, Nebraska 68130 - United States

Status: Contact for availability

Clinical Research Site

Albany, New York 12206 - United States

Status: Contact for availability

Clinical Research Site

Buffalo, New York 14263 - United States

Status: Contact for availability

Clinical Research Site

Philadelphia, Pennsylvania 19111 - United States

Status: Contact for availability

Clinical Research Site

Sioux Falls, South Dakota 57104 - United States

Status: Contact for availability

And 38 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Carcinoma, Renal Cell:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships